The clinical stage bio-pharmaceutical startup Vyome Therapeutics was founded in 2010. It develops new technologies and a pipeline of drugs for antibiotic resistant acne, other opportunistic pathogens and anti-fungal agents in dermatology. It has been funded by the likes of Perceptive Advisors, Romulus Capital, Kalaari Capital, Sabre Partners, and Aarin Capital.